Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Co-founder and managing partner Tim Bello offers perspective on RIA deals, Merchant's "lifecycle equity partners" model, and ...

Annaly Capital Management's potential benefit from lower interest rates in 2025, but the impact of inflation and central bank ...

Still, the strategy’s investment universe remains widespread. The fund offers broad diversification across sectors and companies. For example, while the Russell 1000 Growth Index’s top 10 ...

Bipartisan support for U.S. innovation took center stage at the ROADMAP Summit, uniting leaders to push for sustained CHIPS ...

ADC and SILA's strong balance sheets and growth potential make them prime net lease REITs. Read why they offer resilient ...

Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) today. The company’s ...

LPL Financial (LPLA) announced that the advisors at Charter Oak Wealth Partners have joined LPL Financial’s broker-dealer, RIA and custodial ...